UPDATE : Friday, September 21, 2018
Sillajen reports 1st patient enrollment for Pexa-Vec’s Chinese P3 trials by Lee Han-soo 2018-09-03 17:59
Samyang’s Genexol ranks first in paclitaxel anticancer drug sales by Lee Han-soo 2018-09-03 16:42
Shire’s hemophilia A treatment gains insurance coverage by Lee Han-soo 2018-09-03 14:35
JW unveils foam-type disinfectant by Lee Han-soo 2018-09-03 14:35
Gyeonggi science institution transfers drinking osteoporosis treatment to Dongkook by Lee Han-soo 2018-08-31 15:47
Shire’s hereditary angioedema therapy gets insurance coverage by Lee Han-soo 2018-08-31 13:10
MFDS approves Eisai hepatoma medication as 1st-line treatment by Lee Han-soo 2018-08-30 17:13
PMI unveils new study results, presses Seoul to clarify position by Lee Han-soo 2018-08-30 15:38
GC expands indications for its influenza vaccine by Lee Han-soo 2018-08-30 14:13
FDA to resume biologic licensing procedure for Nabota by Lee Han-soo 2018-08-30 11:26
Yonsei Severance develops new method that can detect cavity by Lee Han-soo 2018-08-29 17:00
Celltrion completes P3 clinical trials for Remsima in Europe by Lee Han-soo 2018-08-29 14:33
Medytox finishes sales approval application for its BTX to Taiwan by Lee Han-soo 2018-08-29 14:33
Dongkook products denied entry into US after refusing FDA inspection by Lee Han-soo 2018-08-29 11:58
Sanofi Genzyme unveils new atopy treatment by Lee Han-soo 2018-08-28 16:42
3 out of 4 patients unable to tell original drugs from generics: survey by Lee Han-soo 2018-08-28 14:23
Elderly patients suffering from severe hearing loss increase by Lee Han-soo 2018-08-28 13:11
Korea enters 'aged society' by Lee Han-soo 2018-08-28 12:32
Daewoong Chairman to step down for insulting employees by Lee Han-soo 2018-08-27 17:58
Foreign patients like Chonnam National University Hwasun Hosptial by Lee Han-soo 2018-08-27 15:42
Back to Top